- Exchange: ASE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
CSL Ltd+ Add to Watchlist
CSL:AU91.1200 AUD 0.5200 0.57%
As of 02:10:31 ET on 05/22/2015.
Company Profile for CSL Ltd (CSL)
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.
Key Executives for CSL Ltd (CSL)
|John ShineChairman||Paul PerreaultCEO/Managing Director|
|Gordon NaylorChief Financial Officer||Mary SontropExec VP:Manufacturing|
|Gregory Boss "Greg"Exec VP:Legal/Gen Cnsl||Karen EtchbergerExec VP:Quality & Busi Service|
|Bob RepellaExec VP:Global Commercial Ops||Laurie CowanSenior VP:Human Resourees|
|Mark DehringDir:Investor Relations||Edward H Bailey "Ed"Secretary|